Viral labyrinthitis and vestibular neuritis

Douglas J Lanska MD MS MSPH

Neuro-Ophthalmology & Neuro-Otology

Updated 05.15.2024
Released 05.26.2023
Expires For CME 05.15.2027

Viral labyrinthitis and vestibular neuritis

Author: Douglas J Lanska MD MS MSPH

See Contributor Disclosures

Viral labyrinthitis and vestibular neuritis

In This Article

Quick Link

Introduction

Overview

This article discusses viral infections of the membranous labyrinth or eighth nerve acquired after birth and without associated neurologic symptoms or signs: vestibular neuritis (ie, vestibular loss alone) and viral labyrinthitis (ie, cochleovestibular loss). Viral labyrinthitis can occur as part of a systemic viral illness, or it may occur with localized involvement of the labyrinth or eighth nerve without apparent systemic involvement. Multiple viruses have been implicated with viral labyrinthitis, but the evidence supporting a viral etiology is often circumstantial. Nevertheless, viral reactivation (eg, latent herpes simplex type 1) in vestibular ganglia is a suspected cause of vestibular neuritis. Diagnostic criteria for these disorders are summarized. The management of the acute phase of vestibular neuritis or viral labyrinthitis is primarily medical, whereas long-term treatment is designed to improve vestibular compensation. Symptomatic medication is indicated during the acute phase to relieve the vertigo and nausea/vomiting. Antihistamines, anticholinergic agents, antidopaminergic agents, and GABAergic agents are useful in acutely suppressing vertiginous symptoms. Corticosteroids are beneficial, but the available evidence does not support the use of antiviral agents.

Key points

	• Vestibular neuritis (ie, vestibular loss alone) and viral labyrinthitis (ie, cochleovestibular loss) may both be caused by viral infections.
	• Viral labyrinthitis can occur as part of a systemic viral illness, or it may occur with localized involvement of the labyrinth or eighth nerve without apparent systemic involvement.
	• Multiple viruses have been implicated with viral labyrinthitis, but the evidence supporting a viral etiology is often circumstantial.
	• Viral reactivation of latent herpes simplex type 1 in vestibular ganglia is a suspected cause of vestibular neuritis.
	• Inclusion criteria for “acute unilateral vestibulopathy” (vestibular neuritis) are (1) acute or subacute onset of sustained vertigo (acute vestibular syndrome) of moderate to severe intensity that is symptomatic for at least 24 hours; (2) spontaneous peripheral vestibular nystagmus; and (3) reduced vestibulo-ocular reflex (VOR) function on the affected side.
	• Exclusions to a diagnosis of “acute unilateral vestibulopathy” (vestibular neuritis) include (1) acute central neurologic symptoms, audiological symptoms, or otologic symptoms; (2) acute central neurologic signs (eg, skew deviation or gaze-evoked nystagmus); (3) acute audiological signs; and (4) the condition is better accounted for by another disease or disorder.
	• The management of the acute phase of vestibular neuritis is primarily medical, whereas long-term treatment is designed to improve vestibular compensation.
	• Symptomatic medication is indicated during the acute phase to relieve the vertigo and nausea/vomiting.
	• Antihistamines, anticholinergic agents, antidopaminergic agents, and GABAergic agents are useful in acutely suppressing vertiginous symptoms.
	• Corticosteroids are beneficial, but the available evidence does not support the use of antiviral agents.

Historical note and terminology

This article considers viral infections of the membranous labyrinth or eighth nerve acquired after birth and without associated neurologic symptoms or signs. Thus, involvement of the membranous labyrinth or eighth nerve due to congenital (in utero) viral infections, herpes zoster oticus (ie, Hunt syndrome or Ramsay Hunt syndrome with facial paresis), and bacterial or carcinomatous meningitis are outside the scope of this article. Virus-mediated sudden deafness without vestibular involvement is also outside the scope of this article.

Vestibular neuritis was first reported in 1949 and was described more fully in 1952 by British neuro-otologists Margaret Ruth Dix (1902–1991) and Charles Skinner Hallpike (1900–1979) (17; 18). Dix and Hallpike, working at the National Hospital, Queen Square, London, had first recognized the disorder in 1946, just after World War II. They argued that it was "some form of organic disease confined to the vestibular apparatus and localized, in all probability, to its peripheral nervous pathways up to and including the vestibular nuclei in the brain stem." They also noted that "[i]n a fairly high proportion of the subjects the onset of the symptoms is associated with some kind of febrile illness, or with evidence of infection of the ears, nose and throat..."

Clinical manifestations

Presentation and course

	• Vestibular neuritis (ie, vestibular loss alone) and viral labyrinthitis (ie, cochleovestibular loss) may both be caused by viral infections.
	• Viral labyrinthitis can occur as part of a systemic viral illness, or it may occur with localized involvement of the labyrinth or eighth nerve without apparent systemic involvement.

Viral labyrinthitis can occur as part of a systemic viral illness, or it may occur with localized involvement of the labyrinth or eighth nerve without apparent systemic involvement (40; 07). Evidence of pharyngitis, tonsillitis, or sinusitis may precede or occur with labyrinthitis (17; 18; 58; 57; 60; 09; 08; 07). With unilateral disease, the nystagmus is typical of peripheral vestibulopathy, with a horizontal-rotatory nystagmus beating toward the healthy ear that is direction-fixed and enhanced by removal of visual fixation (60; 07; 37; 62). Curiously, peripheral vestibular nystagmus in vestibular neuritis is not active at the brainstem level during REM sleep (19).

Viral labyrinthitis typically has an acute or subacute onset with hearing loss, subjective tinnitus, intense vertigo with spontaneous nystagmus, gait unsteadiness/ataxia, and nausea/vomiting.

If the symptoms and signs are predominantly vestibular, without audiological or other neurologic symptoms and signs, the condition is called "vestibular neuronitis" or "vestibular neuritis," the term proposed in the original full description by Dix and Hallpike in 1952 (17; 18). Otoscopy and pure tone audiometry are typically normal, whereas bithermal caloric testing shows moderate to complete canal paresis (17; 18). Although a viral basis is likely in this circumstance, a very careful assessment should be done, especially in the elderly and in those with vascular disease risk factors, particularly to exclude vestibular presentations of posterior circulation ischemia.

Clinical features of vestibular neuritis include (1) a sensation of rotatory vertigo with an acute onset lasting several days; (2) associated nausea; (3) spontaneous horizontal-torsional nystagmus beating toward the unaffected ear; (4) abnormal head impulse test for the involved semicircular canals (ie, abnormal with head impulse test toward the affected ear); (5) unsteadiness with a tendency to fall toward the affected side; (6) deviation of the subjective visual vertical toward the affected side; and (7) normal hearing (07; 63; 37; 62). The head impulse test and caloric irrigation show an ipsilateral deficit of the vestibulo-ocular reflex (63). The clinical features are similar for labyrinthitis, except that hearing is impaired in the affected ear (or ears).

In a longitudinal study of 51 consecutive patients with vestibular neuritis, all patients had abnormal head-shaking nystagmus, caloric stimulation, and head thrust test results as well as at least one otolith-related test abnormality: abnormal tilt of subjective visual vertical, abnormal ocular torsion, or abnormal vestibular evoked myogenic potentials (VEMPs) (41). Less common findings included skew deviation (14%) and a complete ocular tilt reaction (4%) (41), although current diagnostic criteria would exclude cases with skew deviation (62).

There is a significant difference between horizontal vestibulo-ocular reflex (h-VOR) characteristics in vestibular neuritis (ie, vestibular loss alone) and viral labyrinthitis (ie, cochleovestibular loss) (45). Patients with vestibular neuritis exhibit a strong horizontal semicircular canal deficit but no h-VOR asymmetry between the two rotational directions, whereas patients with viral labyrinthitis typically exhibit moderate canal paresis and a marked h-VOR deficit with rotation toward the affected ear. Thus, h-VOR dynamic asymmetry after an acute unilateral inner ear lesion is not due to canal dysfunction alone but instead involves complex adaptive changes in the central VOR; this otolith-canal interaction is mainly linked to the loss of saccular function (45).

Prognosis and complications

In their original description, Dix and Hallpike noted that vestibular neuritis "generally recovers in the course of a few years" (17; 18). Recovery from vestibular neuritis is due to a combination of (a) peripheral restoration of labyrinthine function; (b) somatosensory and visual substitution; and (c) central compensation (63). Peripheral restoration of vestibular function is seldom complete but can be improved with corticosteroids (04; 64; 63). Central compensation can be improved by vestibular rehabilitation exercises (63; 37).

On follow-up, otolith test results returned to normal more rapidly than canal test results in a longitudinal study of 51 consecutive patients with vestibular neuritis (41). The head thrust test was the best predictor of symptom recovery: 80% of patients who continued to report dizziness/vertigo at the last follow-up visit had a positive head thrust test result, whereas only 10% of patients who were not dizzy/vertiginous had a positive head thrust test result.

Residual symptoms often persist months or even years after onset: more than half of affected patients report minor symptoms, such as vertigo with sudden movement of the head and imbalance in the dark (38). Static symptoms invariably resolve, although often not completely, whereas dynamic symptoms and signs (eg, impairment of vestibulo-ocular reflexes from the ipsilesional semicircular canals on head impulse testing) only improve slightly, if at all (27).

Benign paroxysmal positioning vertigo often occurs in patients who have had vestibular neuritis, presumably because of viral disruption of the otolithic membrane (03).

Vestibular neuritis can provoke episodes of atrial fibrillation, which may distract from the correct neurologic diagnosis, delaying potentially beneficial corticosteroid therapy (49).

Biological basis

Etiology and pathogenesis

	• Multiple viruses have been implicated in viral labyrinthitis, but the evidence supporting a viral etiology is often circumstantial.
	• Viral reactivation of latent herpes simplex type 1 in vestibular ganglia is a suspected cause of vestibular neuritis.

Clinical and serologic studies of patients with vestibular neuritis suggest that the viruses are involved in the pathogenesis of this disease, but the exact pathophysiologic mechanisms are unclear. Proposed theories of causation have included viral reactivation, vascular occlusion, and immune-mediated mechanisms (26).

In vestibular neuritis, inflammation of the vestibular nerve is followed by demyelination and loss of function (10). Clinical, laboratory, and neuroradiological findings support an inflammatory component to the pathogenesis: (1) intravenous corticosteroids are useful in facilitating resolution of acute symptoms, presumably by limiting the negative consequences of the inflammatory response (04; 64); (2) higher plasma fibrinogen and CRP levels are present in the acute phase; and (3) there is increased gadolinium uptake in the vestibular nerve and Scarpa ganglion on enhanced MRI.

Multiple viruses have been implicated in viral labyrinthitis, but the evidence supporting a viral etiology is often circumstantial (eg, upper respiratory tract illness within 1 to 2 weeks before onset of vestibular symptoms) (17; 18; 38; 44; 20; 13; 36; 54) (Tables 1–2).

Table 1. Viruses Implicated in Viral Labyrinthitis and Vestibular Neuritis

	• Adenoviral vector-based COVID-19 vaccination (59)
	• Adenovirus (70)
	• Coxsackievirus
	• Cytomegalovirus (44)
	• Enterovirus (unspecified) (21)
	• Epstein-Barr virus
	• Hepatitis E virus (Orthohepevirus A) (68)
	• Herpes simplex type 1 (01; 44)
	• Human herpes virus 6/7 (20)
	• Influenza A virus (60)
	• Influenza B virus (44)
	• Lymphocytic choriomeningitis virus
	• Measles virus (MeV), (rubeola)
	• Mumps virus (MuV)
	• Parainfluenza virus (60)
	• Rubella virus (RuV)
	• SARS-CoV-2 (COVID-19) (06; 13; 23; 36; 54; 47)
	• Varicella zoster virus (40)

Table 2. Viruses Implicated in Viral Labyrinthitis and Vestibular Neuritis, Classified by Nucleic Acid and Envelope

DNA viruses
	• Enveloped, double-stranded DNA
		- Herpesviridae (herpesviruses)
			-- herpes simplex type 1
			-- Epstein-Barr virus
			-- varicella zoster virus (human herpes virus 3)
			-- human herpes virus 6/7
	• Unenveloped, double-stranded DNA
		- Adenoviridae
			-- adenoviruses
			-- adenoviral vector-based vaccines
RNA viruses
	• Enveloped (+) RNA
		- Coronaviridae (coronaviruses)
			-- SARS-CoV-2
		- Matonaviridae
			-- rubella virus
		- Picornaviridae (picornaviruses)
			-- coxsackievirus
		- Hepeviridae
			-- hepatitis E virus
	• Enveloped (-) RNA
		- Paramyxoviridae (paramyxoviruses)
			-- measles virus
			-- mumps virus
			-- human parainfluenza viruses (HPIVs)
		- Orthomyxoviridae (orthomyxoviruses)
			-- influenza A
			-- influenza B
	• Ambisense (+/-) RNA
		- Arenaviridae (arenavirus)
			-- lymphocytic choriomeningitis virus

In patients who died with viral encephalitis and labyrinthitis, labyrinthitis-related pathology was restricted to the scala media, vestibular labyrinth, and internal auditory canal (40). Histologic findings included variable degeneration of the vestibular labyrinth with sloughing of the otolithic membrane, degeneration of the organ of Corti, early encapsulation of the tectorial membrane, degeneration of the stria vascularis, and round cell infiltration of the modiolus and eighth cranial nerve. Unlike herpes zoster oticus, which commonly involves the vestibular nuclei, vestibular neuritis does not involve the vestibular nuclei (69).

The histologic findings in the temporal bones of individuals who had vestibular neuritis suggest viral infection as the main etiologic cause (57; 16; 09; 10). In some cases, pathology has demonstrated viral involvement of the vestibular end organs and eighth cranial nerve (57; 09), typically with maximal damage in the distal branches of the vestibular nerve (16).

Viral reactivation in temporal ganglia is the suspected cause of vestibular neuritis, as well as Bell palsy and sudden hearing loss. Latent herpes simplex type 1 (HSV-1) has been detected in vestibular (Scarpa), geniculate (a sensory ganglion of the facial nerve), and spiral (cochlear) ganglia of human temporal bones by nested polymerase chain reaction (01; 02; 03). Fusion of the viral envelope with the host cell membrane and the entry of the nucleocapsid rely on the binding of multiple envelope proteins to receptors on the host cell membrane and conformational changes (71). HSV-I utilizes microtubules and actin to enter cells retrogradely along axons. After the nucleocapsid is transported to the nucleus, dsDNA is injected into the nucleus through the nuclear pore. Herpesviruses (and other DNA viruses) replicate in specific inclusions within the nucleus (viral replication compartments or VRCs) where viral DNA replication, viral transcription, and virion assembly take place. Mature capsids cross the nuclear membrane and enter the cytoplasm. During this process, the virus is initially coated with an envelope but loses this envelope through fusion with the outer nuclear membrane, so ultimately the virus is released into the cytoplasm without an envelope. The capsid is subsequently reenveloped within an intracellular organelle, where it acquires its mature envelope and completes tegumentation (unique to herpesviruses, tegument is a structure that occupies the space between the nucleocapsid and the envelope and contains many virus-encoded proteins called tegument proteins). During secondary envelopment before being released from the cell, the nucleocapsid and its associated tegument proteins buds into the membrane of a cytoplasmic organelle, leaving an enveloped virion inside a vesicle. The synthesized HSV-1 capsid acquires inner tegument proteins in the cytoplasm, and vesicles provide the outer tegument proteins and the viral membrane. Viruses that have completed the secondary envelopment are released through exocytosis.

HSV-1 structure

HSV-1 is composed of double-stranded DNA, nucleocapsid, tegument, envelope proteins, and a lipid envelope. (Source: Zhao Z, Liu X, Zong Y, Shi X, Sun Y. Cellular processes induced by HSV-1 infections in vestibular neuritis. Vir...
HSV-1 entry into cells via envelope proteins

Although the types and composition of envelope proteins may vary among different viruses in the sporozoan virus family, the fusion of the viral envelope with the host cell membrane and the entry of the nucleocapsid rely on the ...
Intracellular cycle of HSV-1

(Source: Zhao Z, Liu X, Zong Y, Shi X, Sun Y. Cellular processes induced by HSV-1 infections in vestibular neuritis. Viruses 2023;16[1]:12. Creative Commons Attribution 4.0 International [CC BY 4.0] license, creativecommons.org...

The distribution of HSV-1 in human geniculate and vestibular ganglia does not support either viral migration along the anastomosis between the intermediate nerve and the superior vestibular nerve or a preferential latency of HSV-1 in the superior vestibular nerve (01). HSV-1 can be detected in about one third of cases involving the geniculate and vestibular ganglia and the vestibular nuclei; the various patterns of HSV-1 infection of vestibular structures are compatible with virus migration from the vestibular ganglia to the vestibular nuclei and from the ipsilateral to the contralateral vestibular nucleus via commissural fibers (02).

The superior vestibular nerve is more frequently affected than the inferior vestibular nerve, which is partially or totally spared (51; 29). The reasons for this are poorly understood, but anatomical differences and the distribution of latent viruses (eg, herpes simplex type 1) may contribute (51; 29). Latent herpes simplex virus 1 can be demonstrated in only a minority of vestibular ganglia, but infected neurons are typically located only in the superior part (29). However, other studies found no difference in the relative numbers of latency-associated transcripts or production of virions between reactivated, latently infected superior versus inferior vestibular ganglion neurons (51).

An immune cell response process is triggered by a pattern recognition receptors (PRR) signal in response to HSV-1 with secretion of inflammatory cytokines or interferon through the toll-like receptor signaling pathway and the IG-I-like receptor (RLR) signaling pathway (71). The inflammatory cytokines and interferons play crucial roles in controlling viral replication and coordinating innate and adaptive immune responses.

Immune cell response process triggered by pattern recognition receptors signal in response to HSV-1

Inducing the secretion of inflammatory cytokines or interferon (IFN) through the Toll-like receptor (TLR) signaling pathway (left, middle) or the IG-I-like receptor (RLR) signaling pathway (right). In the TLR signaling pathway,...

Vestibular neuritis can produce chronic deafferentation of the vestibular sensory epithelia and the vestibular nuclei (09). Postmortem examination of the brain and temporal bones of a patient with vestibular neuritis showed (1) selective neuronal loss in Scarpa ganglia on the side with absent caloric response; (2) loss of hair cells and an "epithelialization" of the utricular macule and semicircular canal cristae on the deafferented side; and (3) decreased synaptic density in the vestibular nuclei on the deafferented side compared to the normal side.

The vestibulo-cortical system, which includes the parieto-insular vestibular cortex, incorporates an extensive cortical network connected with various subcortical processing areas (eg, oculomotor, somatosensory, visual, and cerebellar regions). Consequently, sudden unilateral vestibular impairment induces a wide variety of cortical and subcortical responses, including changes in regional cerebral glucose metabolism in the vestibular cortex, decreased resting-state activity in the contralateral intraparietal sulcus (close to the human equivalent of the parieto-insular vestibular cortex), and decreased internetwork connectivity between the “default mode” network and multiple other networks (11; 48). Simultaneously, a neural cascade of acute plasticity activity occurs in the visual and multisensory cortex as well as in areas involved in spatial navigation (eg, entorhinal, supramarginal gyrus).

Animal studies. Animal studies have demonstrated that several human viruses can infect the vestibular nerve and the vestibular membranous labyrinth, including rubeola, herpes simplex, cytomegalovirus, and neurotropic strains of influenza A and mumps virus (16; 10).

An animal model of vestibular neuritis has been developed using retroauricular inoculation of herpes simplex virus in mice (31; 30; 10; 22).

Epidemiology

	• Vestibular neuritis is a common cause of peripheral vestibular vertigo, with an annual incidence of 3.5 per 100,000 population.
	• Vestibular neuritis chiefly affects those 30 to 50 years of age, without preference for sex.

Vestibular neuritis is a common cause of peripheral vestibular vertigo, with an estimated annual incidence of 3.5 per 100,000 population (63). In Norway, in the period from 2011 to 2021, the number of patients admitted to the hospital for vestibular neuritis (an approximation of incidence) was 11.2 per 100,000 inhabitants per year (range 8.2–15.3) (24). In Japan, there is also a higher incidence of vestibular neuritis, estimated at 7.1 per 100,000 population, with a male-to-female ratio of 0.96 and mean age of 60.3 years (range 11–94 years) (34).

As recognized by Dix and Hallpike in their initial descriptions, vestibular neuritis "chiefly affects the age group 30 to 50 without preference for sex" (17; 18); this has largely been confirmed by later studies (10).

No clear seasonal pattern has been demonstrated for incident cases of vestibular neuritis (35).

In a case-control study at a tertiary referral hospital, vestibular neuritis in the elderly was associated with cerebral small vessel disease, suggesting (though not proving) that small vessel cerebrovascular disease can contribute to incident vestibular neuritis in the elderly (53).

A genome-wide association study of vestibular neuritis identified four regions containing protein coding genes related to host factors for viral replication or associated with insulin metabolism and resistance (55). Genes related to viral processes include (1) nuclear receptor subfamily 3 group C member 2 (NR3C2), a receptor for mineralocorticoids and glucocorticoids that is a host factor for HSV-1 replication; (2) ankyrin repeat domain 30A (ANKRD30A), which encodes a host factor for HIV-1 infection, shows rapid evolution, and is induced by interferon stimulation; and (3) mediator complex 30 (MED30), which is involved in the replication of HIV-1, with a knockdown leading to impaired viral replication (55). A later case-control study by the same group identified a significant association of the rs12979860-T risk allele for herpes labialis severity with susceptibility to vestibular neuritis, providing further indirect evidence for the involvement of HSV-1 in vestibular neuritis pathogenesis (56).

Differential diagnosis

Confusing conditions

Relevant differential diagnoses include "vestibular pseudoneuritis" due to acute pontomedullary brainstem lesions (eg, AICA, PICA) or cerebellar nodular infarctions (43; 52), vestibular migraine, monosymptomatic-onset Meniere disease, and Ramsay Hunt syndrome (07; 15; 63). Less common considerations include perilymph fistula (07), isolated labyrinthine infarction (07), and demyelinating disease (66). Perilymph fistulas have an abrupt onset associated with head trauma, barotrauma, or sudden strain (eg, heavy lifting, coughing, or sneezing) and may be associated with chronic otitis with cholesteatoma (07).

Skew deviation is a specific but insensitive (40%) sign of vestibular pseudoneuritis (15).

In patients with acute vestibular syndrome, a negative horizontal head impulse test (ie, normal VOR) strongly suggests a central lesion with a "pseudo-labyrinthine" presentation (52). Most patients with acute peripheral vestibulopathy from a stroke have a negative horizontal head impulse test, but contrary to conventional wisdom, about 10% have a positive horizontal head impulse test. In particular, patients with lateral pontine or cerebellar strokes (eg, vestibulocerebellar, pontocerebellar, and pontocerebello-labyrinthine strokes) may have a positive horizontal head impulse test. Therefore, a positive horizontal head impulse test does not prove that an acute vestibular syndrome is due to peripheral (and relatively benign) pathology (eg, vestibular neuritis). Additional clinical features (eg, directionality of nystagmus, severity of truncal instability, nature of hearing loss) and neuroimaging should be considered in patients with acute vestibular syndrome with a positive horizontal head impulse test before a central localization can be confidently excluded. Head impulse gain and saccade analysis may further help distinguish pontine cerebellar stroke and vestibular neuritis (14).

Diagnostic workup

	• Inclusion criteria for “acute unilateral vestibulopathy” (vestibular neuritis) are (1) acute or subacute onset of sustained vertigo (acute vestibular syndrome) of moderate to severe intensity that is symptomatic for at least 24 hours; (2) spontaneous peripheral vestibular nystagmus; and (3) reduced vestibulo-ocular reflex (VOR) function on the affected side.
	• Exclusions to a diagnosis of “acute unilateral vestibulopathy” (vestibular neuritis) include (1) acute central neurologic symptoms, audiological symptoms, or otologic symptoms; (2) acute central neurologic signs (eg, skew deviation or gaze-evoked nystagmus); (3) acute audiological signs; and (4) the condition is better accounted for by another disease or disorder.

Careful bedside examination of patients with suspected labyrinthitis or vestibular neuritis is important for both diagnosis and prognosis (46). In particular, bedside oculomotor findings play a critical role in differentiating vestibular neuritis from stroke and other pathologies.

The diagnostic hallmarks of vestibular neuritis are (1) rotatory vertigo with an acute onset lasting several days; (2) associated nausea; (3) spontaneous horizontal-torsional nystagmus beating toward the unaffected ear; (4) abnormal head impulse test for the involved semicircular canals (ie, toward the affected ear); (5) unsteadiness with a tendency to fall toward the affected side; (6) deviation of the subjective visual vertical toward the affected side; (7) ipsilesional caloric paresis (with electro- or videonystagmography); (8) decreased responses of vestibular-evoked myogenic potentials during stimulation of the affected ear; and (9) normal pure tone audiometry (07; 63; 37; 62). The head impulse test and caloric irrigation show an ipsilateral deficit of the vestibulo-ocular reflex (63). The diagnostic hallmarks are similar for labyrinthitis, except that hearing is impaired in the affected ear (or ears), which can be quantified with pure tone audiometry.

The Barany Society has developed diagnostic criteria for “acute unilateral vestibulopathy” (vestibular neuritis) (Table 3), variants (ie, for evolving and "probable" cases not meeting the full diagnostic criteria), and for a history of acute unilateral vestibulopathy (vestibular neuritis) (Table 4) (62).

Table 3. Barany Society Diagnostic Criteria For “Acute Unilateral Vestibulopathy” (Vestibular Neuritis)

Inclusions (all required)
	• Acute or subacute onset of sustained vertigo (acute vestibular syndrome) of moderate to severe intensity that is symptomatic for at least 24 hours
	• Spontaneous peripheral vestibular nystagmus, ie, with a trajectory appropriate to the semicircular canal afferents involved (generally horizontal-torsional), direction-fixed, and enhanced by removal of visual fixation
	• Reduced vestibulo-ocular reflex (VOR) function on the affected side (ie, opposite the direction of the fast phase of the spontaneous nystagmus)
Exclusions
	• Acute central neurologic symptoms, audiological symptoms (eg, hearing loss or tinnitus), or otologic symptoms (eg, otalgia)
	• Acute central neurologic signs, including central ocular motor or central vestibular signs (eg, skew deviation, gaze-evoked nystagmus)
	• Acute audiological signs
	• Better accounted for by another disease or disorder
	(62)

The Barany Society created a separate diagnostic category of “acute unilateral vestibulopathy in evolution” (vestibular neuritis in evolution) for symptoms that have persisted for more than 3 hours but have not yet lasted for at least 24 hours (62); the diagnostic criteria are otherwise unchanged from those for “acute unilateral vestibulopathy” (vestibular neuritis). If there is no clear evidence of reduced VOR function by bedside examination on the side opposite the direction of the fast phase of the spontaneous nystagmus, but the diagnostic criteria are otherwise met, the Barany Society categorizes this as “probable acute unilateral vestibulopathy” (probable vestibular neuritis) (62).

Table 4. Barany Society Diagnostic Criteria For “History of Acute Unilateral Vestibulopathy” (History of Vestibular Neuritis)

Inclusions (all required)
	• Acute or subacute onset of sustained vertigo (acute vestibular syndrome) that was symptomatic for at least 24 hours and then slowly decreased in intensity over days
	• Unilateral reduced VOR function
Exclusions
	• History of acute central neurologic symptoms or audiological symptoms (eg, hearing loss or tinnitus)
	• History of acute central neurologic or audiological signs
	• Better accounted for by another disease or disorder
	(62)

Acute vestibular neuritis most often affects both vestibular nerve divisions (05; 65). Canal-plane video head impulse testing (ie, horizontal vHIT) identifies superior nerve dysfunction, which is uniformly present in patients with vestibular neuritis tested acutely, whereas both cervical/vestibular evoked myogenic potentials and posterior vHIT are necessary to diagnose inferior vestibular nerve involvement (50; 65). Rare cases of isolated "inferior vestibular neuritis" have been reported with symptoms consistent with vestibular neuritis but normal caloric testing (05; 50). A slight, asymptomatic, position-dependent nystagmus may be observed with the pathological ear down in patients with inferior vestibular neuritis (50). Unilateral loss of vestibular evoked myogenic potentials is found in these cases (50). Thorough analysis of corrective saccades in vHITs can improve the differentiation of posterior circulation strokes from vestibular neuritis even before MRI. Head-impulse responses that deviate from the findings expected in vestibular neuritis include normal, contralaterally positive, and negative saccadic amplitude asymmetry (ie, greater cumulative saccadic amplitude contralaterally) (42).

Brainstem evoked response audiometry (BERA) shows prolonged latencies and I–III interpeak interval (10).

Higher plasma fibrinogen and CRP levels may be demonstrated in the acute phase (10).

Increased gadolinium uptake may be demonstrated in the vestibular nerve and Scarpa ganglion on enhanced MRI (39; 10). High-field-strength MRI (3.0 T) with high-dose (0.3 mmol/kg of body weight) gadolinium-pentetic acid may show isolated enhancement of the vestibular nerve on the affected side, supporting the hypothesis of a viral and inflammatory cause of acute vestibular neuritis (39).

Brain imaging is indicated to exclude a vascular basis, even in patients with typical clinical findings, particularly when the patient is elderly or has known vascular disease or significant vascular risk factors, unprecedented headache, a negative head impulse test, or severe unsteadiness (67; 37).

Management

	• The management of the acute phase of vestibular neuritis is primarily medical, whereas long-term treatment is designed to improve vestibular compensation.
	• Symptomatic medication is indicated during the acute phase to relieve the vertigo and nausea/vomiting.
	• Antihistamines, anticholinergic agents, antidopaminergic agents, and GABAergic agents are useful in acutely suppressing vertiginous symptoms.
	• Corticosteroids are beneficial, but available evidence does not support the use of antiviral agents.

The management of the acute phase of vestibular neuritis is primarily medical, whereas long-term treatment is designed to improve vestibular compensation.

Symptomatic medication is indicated during the acute phase to relieve the vertigo and nausea/vomiting. Antihistamines, anticholinergic agents, antidopaminergic agents, and GABAergic agents (eg, gabapentin, benzodiazepines) are useful in acutely suppressing vertiginous symptoms (07). Antiemetics and vestibular suppressants should be withdrawn as soon as feasible (preferably after the first several days) because, at least theoretically, their prolonged use may impede the process of central vestibular compensation (67).

Corticosteroids and antiviral agents have also been used in the treatment of vestibular neuritis, but the available evidence provides no convincing basis to use antiviral agents (07; 64; 26). Corticosteroids are useful in facilitating resolution of acute symptoms, presumably by limiting the negative consequences of the inflammatory response (04; 64; 25; 33; 12; 28). In a controlled trial, methylprednisolone was more effective than placebo in controlling acute symptoms (04). In a later trial, methylprednisolone, valacyclovir, and combined methylprednisolone plus valacyclovir were administered to three patient groups with vestibular neuritis (64). Methylprednisolone alone was effective, whereas valacyclovir had no evident efficacy in the treatment of vestibular dysfunction, either alone or in combination with methylprednisolone. In this trial, methylprednisolone was administered as a single morning dose on a tapering schedule over about 3 weeks: 100 mg on days 1 to 3; 80 mg on days 4 to 6; 60 mg on days 7 to 9; 40 mg on days 10 to 12; 20 mg on days 13 to 15; 10 mg on days 16 to 18; and 10 mg on days 20 and 22 (64).

Early resumption of normal activity should be encouraged to promote compensation (67). Directed vestibular rehabilitation further hastens recovery (61; 63; 67; 37; 25; 33; 28; 32). The combination of vestibular rehabilitation and steroids is more effective than steroids alone in the treatment of patients with vestibular neuritis.

Media

References

01: Arbusow V, Schulz P, Strupp M, et al. Distribution of herpes simplex virus type 1 in human geniculate and vestibular ganglia: implications for vestibular neuritis. Ann Neurol 1999;46(3):416-9.** PMID 10482275
02: Arbusow V, Strupp M, Wasicky R, Horn AK, Schulz P, Brandt T. Detection of herpes simplex virus type 1 in human vestibular nuclei. Neurology 2000;55(6):880-2. PMID 10994016
03: Arbusow V, Theil D, Strupp M, Mascolo A, Brandt T. HSV-1 not only in human vestibular ganglia but also in the vestibular labyrinth. Audiol Neurootol 2001;6(5):259-62. PMID 11729328
04: Ariyasu L, Byl FM, Sprague MS, Adour KK. The beneficial effect of methylprednisolone in acute vestibular vertigo. Arch Otolaryngol Head Neck Surg 1990;116(6):700-3. PMID 2187486
05: Aw ST, Fetter M, Cremer PD, Karlberg M, Halmagyi GM. Individual semicircular canal function in superior and inferior vestibular neuritis. Neurology 2001;57(5):768-74. PMID 11552001
06: Babu TA, Sarkar MK, Sharmila V. COVID-19 vestibular neuritis (CVN) in a healthcare worker: a rare complication of COVID-19 infection. J R Coll Physicians Edinb 2021;51(2):199-207. PMID 34131685
07: Baloh RW. Clinical practice. Vestibular neuritis. N Engl J Med 2003;348(11):1027-32.** PMID 12637613
08: Baloh RW. Dizziness, hearing loss, and tinnitus. Philadelphia: FA Davis Company, 1998.**
09: Baloh RW, Ishyama A, Wackym PA, Honrubia V. Vestibular neuritis: clinical-pathologic correlation. Otolaryngol Head Neck Surg 1996;114(4):586-92. PMID 8643269
10: Bartual-Pastor J. Vestibular neuritis: etiopathogenesis. Rev Laryngol Otol Rhinol (Bord) 2005;126(4):279-81. PMID 16496559
11: Bense S, Bartenstein P, Lochmann M, Schlindwein P, Brandt T, Dieterich M. Metabolic changes in vestibular and visual cortices in acute vestibular neuritis. Ann Neurol 2004;56(5):624-30. PMID 15449325
12: Bogdanova A, Dlugaiczyk J, Heckmann JG, Schwab S. Corticosteroids in patients with vestibular neuritis: an updated meta-analysis. Acta Neurol Scand 2022;146(5):429-39. PMID 36029039
13: Bokhary H, Chaudhry S, Abidi SMR. Labyrinthitis: a rare consequence of COVID-19 infection. Cureus 2021;13(8):e17121. PMID 34548960
14: Chen L, Todd M, Halmagyi GM, Aw S. Head impulse gain and saccade analysis in pontine-cerebellar stroke and vestibular neuritis. Neurology 2014;83(17):1513-22. PMID 25253747
15: Cnyrim CD, Newman-Toker D, Karch C, Brandt T, Strupp M. Bedside differentiation of vestibular neuritis from central "vestibular pseudoneuritis." J Neurol Neurosurg Psychiatry 2008;79(4):458-60. PMID 18344397
16: Davis LE. Viruses and vestibular neuritis: review of human and animal studies. Acta Otolaryngol Suppl 1993;503:70-3.** PMID 8470506
17: Dix MR, Hallpike CS. The pathology symptomatology and diagnosis of certain common disorders of the vestibular system. Proc R Soc Med 1952a;45(6):341-54.** PMID 14941845
18: Dix MR, Hallpike CS. The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system. Ann Otol Rhinol Laryngol 1952b;61(4):987-1016.** PMID 13008328
19: Eisensehr I, Noachtar S, Strupp M, von Lindeiner H, Brandt T, Büttner U. Absence of nystagmus during REM sleep in patients with vestibular neuritis. J Neurol Neurosurg Psychiatry 2001;71(3):386-9. PMID 11511716
20: El-Hussein M, El-Tawil C, Nakhle R, Souaiby N. HHV 6-7 reactivation causing Pityriasis Rosea and labyrinthitis: a case report. Am J Emerg Med 2020;38(9):1969.e1-e3. PMID 32553563
21: Ergul Y, Ekici B, Tastan Y, Sezer T, Uysal S. Vestibular neuritis caused by enteroviral infection. Pediatr Neurol 2006;34(1):45-6. PMID 16376278
22: Esaki S, Goshima F, Kimura H, et al. Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice. Acta Otolaryngol 2011;131(7):684-91. PMID 21526906
23: Giannantonio S, Scorpecci A, Montemurri B, Marsella P. Case of COVID-19-induced vestibular neuritis in a child. BMJ Case Rep 2021;14(6):e242978. PMID 34078625
24: Goplen FK, Wiik R. Patients admitted to hospital for vestibular neuritis in 2011-2021. Tidsskr Nor Laegeforen 2023;143(14). PMID 37830970
25: Goudakos JK, Markou KD, Psillas G, Vital V, Tsaligopoulos M. Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2014;140(5):434-40. PMID 24604142
26: Greco A, Macri GF, Gallo A, et al. Is vestibular neuritis an immune related vestibular neuropathy inducing vertigo? J Immunol Res 2014;2014:459048. PMID 24741601
27: Halmagyi GM, Weber KP, Curthoys IS. Vestibular function after acute vestibular neuritis. Restor Neurol Neurosci 2010;28(1):37-46. PMID 20086281
28: Hidayati HB, Imania HAN, Octaviana DS, et al. Vestibular rehabilitation therapy and corticosteroids for vestibular neuritis: a systematic review and meta-analysis of randomized controlled trials. Medicina (Kaunas) 2022;58(9):1221. PMID 36143898
29: Himmelein S, Lindemann A, Sinicina I, et al. Differential involvement during latent herpes simplex virus 1 infection of the superior and inferior divisions of the vestibular ganglia: implications for vestibular neuritis. J Virol 2017;91(14):e00331-17. PMID 28446678
30: Hirata Y, Gyo K, Yanagihara N. Herpetic vestibular neuritis: an experimental study. Acta Otolaryngol Suppl 1995;519:93-6. PMID 7610901
31: Hirata Y, Sugita T, Gyo K, Yanagihara N. Experimental vestibular neuritis induced by herpes simplex virus. Acta Otolaryngol Suppl 1993;503:79-81. PMID 8385869
32: Huang HH, Chen CC, Lee HH, et al. Efficacy of vestibular rehabilitation in vestibular neuritis: a systematic review and meta-analysis. Am J Phys Med Rehabil 2024;103(1):38-46. PMID 37339059
33: Ismail EI, Morgan AE, Abdel Rahman AM. Corticosteroids versus vestibular rehabilitation in long-term outcomes in vestibular neuritis. J Vestib Res 2018;28(5-6):417-24. PMID 30714984
34: Iwasaki S, Kawahara T, Miyashita T, et al. Estimated incidence and characteristics of vestibular neuritis in Japan: a nationwide survey. Auris Nasus Larynx 2024;51(2):343-6. PMID 37838569
35: Jeong J, Nam Y, Oh J, Choi HS. Monthly and seasonal variations in vestibular neuritis. Medicine (Baltimore) 2022;101(26):e29787. PMID 35777043
36: Jeong M, Ocwieja KE, Han D, et al. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun Med (Lond) 2021;1(1):44. PMID 34870285
37: Jeong SH, Kim HJ, Kim JS. Vestibular neuritis. Semin Neurol 2013;33(3):185-94.** PMID 24057821
38: Johnson RT. Vestibular neuritis, or driving dizzily through Donegal. N Engl J Med 2004;351(4):322-3. PMID 15269310
39: Karlberg M, Annertz M, Magnusson M. Acute vestibular neuritis visualized by 3-T magnetic resonance imaging with high-dose gadolinium. Arch Otolaryngol Head Neck Surg 2004;130(2):229-32. PMID 14967757
40: Karmody CS. Viral labyrinthitis: early pathology in the human. Laryngoscope 1983;93(12):1527-33. PMID 6606097
41: Kim HA, Hong JH, Lee H, et al. Otolith dysfunction in vestibular neuritis: recovery pattern and a predictor of symptom recovery. Neurology 2008;70(6):449-53.** PMID 18250289
42: Kim SH, Lee SU, Cho BH, et al. Analyses of head-impulse tests in patients with posterior circulation stroke and vestibular neuritis. Neurology 2023;100(23):e2374-85. PMID 37076307
43: Lee H, Cho YW. A case of isolated nodulus infarction presenting as a vestibular neuritis. J Neurol Sci 2004;221(1-2):117-9. PMID 15178226
44: Liu B, Li B, Zhang L, et al. Vestibular function features and prognosis of vestibular neuritis in children. [Article in Chinese] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018;53(12):899-903. PMID 30585000
45: Maire R, Van Melle G. Horizontal vestibulo-ocular reflex dynamics in acute vestibular neuritis and viral labyrinthitis: evidence of otolith-canal interaction. Acta Otolaryngol 2004;124(1):36-40. PMID 14977076
46: Mandala M, Nuti D, Broman AT, Zee DS. Effectiveness of careful bedside examination in assessment, diagnosis, and prognosis of vestibular neuritis. Arch Otolaryngol Head Neck Surg 2008;134(2):164-9. PMID 18283159
47: Mat Q, Noël A, Loiselet L, et al. Vestibular neuritis as clinical presentation of COVID-19. Ear Nose Throat J 2023;102(3):NP129-32. PMID 33570425
48: Micarelli A, Chiaravalloti A, Schillaci O, Ottaviani F, Alessandrini M. Aspects of cerebral plasticity related to clinical features in acute vestibular neuritis: a "starting point" review from neuroimaging studies. Acta Otorhinolaryngol Ital 2016;36(2):75-84. PMID 27196070
49: Mirabelli AG, Dick R, Infeld B, Gerraty RP. Acute vestibular neuritis may provoke atrial fibrillation. Intern Med J 2023;53(8):1429-34. PMID 35607774
50: Monstad P, Økstad S, Mygland A. Inferior vestibular neuritis: 3 cases with clinical features of acute vestibular neuritis, normal calorics but indications of saccular failure. BMC Neurol 2006;6:45. PMID 17169144
51: Nayak S, He L, Roehm PC. Superior versus inferior vestibular neuritis: are there intrinsic differences in infection, reactivation, or production of infectious particles between the vestibular ganglia? Otol Neurotol 2015;36(7):1266-74. PMID 25978655
52: Newman-Toker DE, Kattah JC, Alvernia JE, Wang DZ. Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis. Neurology 2008;70(24 Pt 2):2378-85. PMID 18541870
53: Oussoren FK, Poulsen LNF, Kardux JJ, Schermer TR, Bruintjes TD, van Leeuwen RB. Cerebral small vessel disease in elderly patients with vestibular neuritis. Front Neurol 2022;13:818533. PMID 35432164
54: Perret M, Bernard A, Rahmani A, Manckoundia P, Putot A. Acute labyrinthitis revealing COVID-19. Diagnostics (Basel) 2021;11(3):482. PMID 33803267
55: Rujescu D, Hartmann AM, Giegling I, et al. Genome-wide association study in vestibular neuritis: involvement of the host factor for HSV-1 replication. Front Neurol 2018;9:591. PMID 30079052
56: Rujescu D, Herrling M, Hartmann AM, et al. High-risk allele for herpes labialis severity at the IFNL3/4 locus is associated with vestibular neuritis. Front Neurol 2020;11:570638. PMID 33133009
57: Schuknecht HF. Neurolabyrinthitis. Viral infections of the peripheral auditory and vestibular systems. In: Nomura Y, editor. Hearing loss and dizziness. Tokyo: Igaku-Shoin, 1985: 1-12.
58: Schuknecht HF, Kitamura K. Second Louis H Clerf lecture. Vestibular neuritis. Ann Otol Rhinol Laryngol Suppl 1981;90(1 Pt 2):1-19. PMID 6781398
59: Shahali H, Hamidi Farahani R, Hazrati P, Hazrati E. Acute vestibular neuritis: a rare complication after the adenoviral vector-based COVID-19 vaccine. J Neurovirol 2022;28(4-6):609-15. PMID 35877063
60: Silvoniemi P. Vestibular neuronitis. An otoneurological evaluation. Acta Otolaryngol Suppl 1988;453:1-72. PMID 3068952
61: Strupp M, Arbusow V, Maag KP, Gall C, Brandt T. Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis. Neurology 1998;51(3):838-44. PMID 9748036
62: Strupp M, Bisdorff A, Furman J, et al. Acute unilateral vestibulopathy/vestibular neuritis: diagnostic criteria. J Vestib Res 2022;32(5):389-406.** PMID 35723133
63: Strupp M, Brandt T. Vestibular neuritis. Semin Neurol 2009;29(5):509-19.** PMID 19834862
64: Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004;351(4):354-61.** PMID 15269315
65: Taylor RL, McGarvie LA, Reid N, Young AS, Halmagyi GM, Welgampola MS. Vestibular neuritis affects both superior and inferior vestibular nerves. Neurology 2016;87(16):1704-12. PMID 27694256
66: Valente P, Pinto I, Aguiar C, Castro E, Condé A, Larangeiro J. Acute vestibular syndrome and hearing loss mimicking labyrinthitis as initial presentation of multiple sclerosis. Int J Pediatr 2020;134:110048. PMID 32353617
67: Walker MF. Treatment of vestibular neuritis. Curr Treat Options Neurol 2009;11(1):41-5. PMID 19094835
68: Woolson KL, Forbes A, Vine L, et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther 2014;40(11-12):1282-91. PMID 25303615
69: Yacovino DA, Perez Akly MS, Ibañez T, Cherchi M. Vestibular nucleus involvement in patients with acute vertigo due to herpes zoster oticus or vestibular neuritis. Neurology 2023;101(14):e1461-5. PMID 37460229
70: Zannolli R, Zazzi M, Muraca MC, Macucci F, Buoni S, Nuti D. A child with vestibular neuritis is adenovirus implicated? Brain Dev 2006;28(6):410-2. PMID 16504444
71: Zhao Z, Liu X, Zong Y, Shi X, Sun Y. Cellular processes induced by HSV-1 infections in vestibular neuritis. Viruses 2023;16(1):12. PMID 38275947
72: References especially recommended by the author or editor for general reading.

Patient Profile

Age range of presentation: Typical: 30 to 50 years
Sex preponderance: No sex preponderance
Heredity: No hereditary factors
Population groups selectively affected: No population group selectively affected
Occupation groups selectively affected: No occupation group selectively affected

ICD & OMIM codes

ICD-10: Vestibular neuritis, Disorders of vestibular function: H81

Viral labyrinthitis, Other diseases of the inner ear: H83
ICD-11: Other specified viral infections of the central nervous system: 1C8Y

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Viral labyrinthitis and vestibular neuritis

Differential Diagnosis

vestibular pseudoneuritis due to acute pontomedullary brainstem lesions
cerebellar nodular infarctions
vestibular migraine
monosymptomatic-onset Meniere disease
Ramsay Hunt syndrome
- perilymph fistula
- isolated labyrinthine infarction
- demyelinating disease

Viral labyrinthitis and vestibular neuritis

Viral labyrinthitis and vestibular neuritis

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Table 1. Viruses Implicated in Viral Labyrinthitis and Vestibular Neuritis

Table 2. Viruses Implicated in Viral Labyrinthitis and Vestibular Neuritis, Classified by Nucleic Acid and Envelope

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Table 3. Barany Society Diagnostic Criteria For “Acute Unilateral Vestibulopathy” (Vestibular Neuritis)

Table 4. Barany Society Diagnostic Criteria For “History of Acute Unilateral Vestibulopathy” (History of Vestibular Neuritis)

Management

Media

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Common maculopathies

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Chronic progressive external ophthalmoplegia

Von Hippel-Lindau disease

Giant cell arteritis

Viral labyrinthitis and vestibular neuritis

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Table 1. Viruses Implicated in Viral Labyrinthitis and Vestibular Neuritis

Table 2. Viruses Implicated in Viral Labyrinthitis and Vestibular Neuritis, Classified by Nucleic Acid and Envelope

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Table 3. Barany Society Diagnostic Criteria For “Acute Unilateral Vestibulopathy” (Vestibular Neuritis)

Table 4. Barany Society Diagnostic Criteria For “History of Acute Unilateral Vestibulopathy” (History of Vestibular Neuritis)

Management

Media

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Common maculopathies

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Chronic progressive external ophthalmoplegia

Von Hippel-Lindau disease

Giant cell arteritis

This is an article preview.
Start a Free Account
to access the full version.